敏實(00425.HK)夥億航智能(EH.US)進軍低空飛行器市場
敏實集團(00425.HK)宣布,全資附屬敏翼與低空飛行器生產商億航智能(EH.US)旗下億航訂立開發委托服務協議,敏翼將為億航提供包括飛機艙門等低空飛行器指定零部件的設計、開發、製造與組裝服務,並在相關機型量產後持續供應。
敏實集團另一全資附屬敏實汽研亦與億航簽訂為期五年的戰略合作協議,雙方將聯合研發低空飛行器相關業務,合作範圍涵蓋低空飛行器機體零部件及旋翼系統的聯合研發,以及構建可部署及運行低空飛行器的交通場景。
集團表示,憑藉自身的製造佈局及汽車零部件技術積累,能與低空產業在製造工藝、零部件等方面具有高度協同與產業互通性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.